These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 29725421)
21. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network. Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871 [TBL] [Abstract][Full Text] [Related]
22. The prognostic landscape of tumor-infiltrating immune cells in lung squamous cell carcinoma. Guo L; Yi J; Liu M; Li J Ann Transl Med; 2021 May; 9(9):799. PubMed ID: 34268412 [TBL] [Abstract][Full Text] [Related]
23. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
24. Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma. Wu W; Wang X; Shan C; Li Y; Li F Onco Targets Ther; 2018; 11():5025-5034. PubMed ID: 30174440 [TBL] [Abstract][Full Text] [Related]
25. TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma. Peng Y; Qiu B; Tan F; Xu J; Bie F; He H; Liu L; Tian H; Bai G; Zhou B; Li Y; Huai Q; Yang Z; Gao S Thorac Cancer; 2022 Jul; 13(14):2014-2023. PubMed ID: 35611464 [TBL] [Abstract][Full Text] [Related]
26. The critical role of serum thymidine kinase 1(STK1) in predicting prognosis for immunotherapy in T4 stage lung squamous cell carcinoma. Pan J; Liu H; Li S; Wei W; Mai J; Bian Y; Ning S; Li J; Zhang L Heliyon; 2023 Mar; 9(3):e14129. PubMed ID: 36938402 [TBL] [Abstract][Full Text] [Related]
27. Increased LOXL2 expression is related to poor prognosis in lung squamous cell carcinoma. Cao L; Zhong J; Liu Z; Jiang J; Zhu C; Liu F; Wang B J Thorac Dis; 2024 Jan; 16(1):581-592. PubMed ID: 38410543 [TBL] [Abstract][Full Text] [Related]
28. Construction of a Two-Gene Immunogenomic-Related Prognostic Signature in Lung Squamous Cell Carcinoma. Zhang X; Xiao J; Fu X; Qin G; Yu M; Chen G; Li X Front Mol Biosci; 2022; 9():867494. PubMed ID: 35463955 [TBL] [Abstract][Full Text] [Related]
29. Chen R; Hong Q; Jiang J; Chen X; Jiang Z; Wang J; Liu S; Duan S; Shi S Oncol Lett; 2017 Oct; 14(4):4989-4994. PubMed ID: 29085512 [TBL] [Abstract][Full Text] [Related]
30. Systematic analysis using a bioinformatics strategy identifies SFTA1P and LINC00519 as potential prognostic biomarkers for lung squamous cell carcinoma. Yin YZ; Yao SH; Li CG; Ma YS; Kang ZJ; Zhang JJ; Jia CY; Hou LK; Qin SS; Fan X; Zhang H; Yang MD; Zhang DD; Lu GX; Wang HM; Gu LP; Tian LL; Wang PY; Cao PS; Wu W; Cao ZY; Lv ZW; Shi BW; Wu CY; Jiang GX; Fu D; Yu F Am J Transl Res; 2021; 13(1):168-182. PubMed ID: 33527016 [TBL] [Abstract][Full Text] [Related]
31. Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer. Han P; Liu Q; Xiang J Oncol Lett; 2020 Jan; 19(1):707-716. PubMed ID: 31897186 [TBL] [Abstract][Full Text] [Related]
32. A nine-long non-coding RNA signature for prognosis prediction of patients with lung squamous cell carcinoma. Huang G; Huang Q; Xie Z; Zhou H; Cao J; Shi L; Yang M Cancer Biomark; 2019; 26(3):239-247. PubMed ID: 31524143 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of high expression of miR-452-5p in lung squamous cell carcinoma. Gan XN; Gan TQ; He RQ; Luo J; Tang RX; Wang HL; Zhou H; Qing H; Ma J; Hu XH; Chen G Oncol Lett; 2018 May; 15(5):6418-6430. PubMed ID: 29616113 [TBL] [Abstract][Full Text] [Related]
34. High expression of SLC6A10P contributes to poor prognosis in lung adenocarcinoma. Yuan K; Gao ZJ; Yuan WD; Yuan JQ; Wang Y Int J Clin Exp Pathol; 2018; 11(2):720-726. PubMed ID: 31938158 [TBL] [Abstract][Full Text] [Related]
35. MicroRNAs associated with lung squamous cell carcinoma: New prognostic biomarkers and therapeutic targets. Qi L; Gao C; Feng F; Zhang T; Yao Y; Wang X; Liu C; Li J; Li J; Sun C J Cell Biochem; 2019 Nov; 120(11):18956-18966. PubMed ID: 31241205 [TBL] [Abstract][Full Text] [Related]
36. The expression, significance and function of cancer susceptibility candidate 9 in lung squamous cell carcinoma: A bioinformatics and in vitro investigation. Gao L; Guo YN; Zeng JH; Ma FC; Luo J; Zhu HW; Xia S; Wei KL; Chen G Int J Oncol; 2019 May; 54(5):1651-1664. PubMed ID: 30896821 [TBL] [Abstract][Full Text] [Related]
37. High levels of CCL2 or CCL4 in the tumor microenvironment predict unfavorable survival in lung adenocarcinoma. Li L; Liu YD; Zhan YT; Zhu YH; Li Y; Xie D; Guan XY Thorac Cancer; 2018 Jul; 9(7):775-784. PubMed ID: 29722145 [TBL] [Abstract][Full Text] [Related]
38. Clinical significance of miRNA‑1 and its potential target gene network in lung squamous cell carcinoma. Li X; Qin M; Huang J; Ma J; Hu X Mol Med Rep; 2019 Jun; 19(6):5063-5078. PubMed ID: 31059033 [TBL] [Abstract][Full Text] [Related]
39. Integrated Analysis of the Functions and Prognostic Values of RNA Binding Proteins in Lung Squamous Cell Carcinoma. Li W; Li X; Gao LN; You CG Front Genet; 2020; 11():185. PubMed ID: 32194639 [TBL] [Abstract][Full Text] [Related]
40. SFTA1P, LINC00968, GATA6-AS1, TBX5-AS1, and FEZF1-AS1 are crucial long non-coding RNAs associated with the prognosis of lung squamous cell carcinoma. Xiong Y; Zhang X; Lin Z; Xiong A; Xie S; Liang J; Zhang W Oncol Lett; 2019 Oct; 18(4):3985-3993. PubMed ID: 31579094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]